Kratom Scientists Pen Letter Questioning Case Report Review

Dr. Cachat and Brian look at a letter (Smith et al, 2022) authored by former Kratom Science Podcast guests Dr. Kirsten Smith, Dr. Oliver Grundmann, Dr. Chris McCurdy, Dr. Darshan Singh, and other experts in the kratom field. The letter questions a systematic review (Broyan et al, 2022) of kratom case reports that offers buprenorphine as a solution to “kratom use disorder”.

Mitragynine and 7- hydroxymitragynine: 
Pharmacodynamic studies

Kratom Lords  >  Kratom University  >  Kratom Research  >  Kratom Scientists Pen Letter Questioning Case Report Review ​

Join the Kratom Lords Family

Sign up to get 10% off on your first order. Stay updated on the latest deals, flash sales, latest Kratom news and more!

Kratom-related case reports typically originate with patients showing up to emergency rooms and physicians’ offices with symptoms. In these case reports, kratom product samples are rarely if ever tested for adulterants or contamination. The strength of the kratom product and dose levels seem to nearly always go unreported or wildly misreported (for example, the Broyan et al. review the Smith et al. letter addresses here claims the patients consumed an average of 92 grams of kratom per day). Furthermore, history or current use of other drugs is often overlooked.

Dr. Jon also talks about his trouble getting public data on cannabis testing and use trends from the State of Ohio’s Marijuana Enforcement Tracking Reporting & Compliance (METRC) program.

References

  • Broyan, V. R., Brar, J. K., Allgaier Student, T., & Allgaier, J. T. (2022). Long-term buprenorphine treatment for kratom use disorder: A case series. Substance abuse, 43(1), 763–766. https://doi.org/10.1080/08897077.2021.2010250
  • Smith, K. E., Dunn, K. E., Epstein, D. H., Feldman, J. D., Garcia-Romeu, A., Grundmann, O., Henningfield, J. E., McCurdy, C. R., Rogers, J. M., Schriefer, D., Singh, D., & Weiss, S. T. (2022). Need for clarity and context in case reports on kratom use, assessment, and intervention. Substance abuse, 43(1), 1221–1224. https://doi.org/10.1080/08897077.2022.2074608
  • https://www.metrc.com/

Source : kratomscience.com

Notice:

The above article is a repost. Please refer to the source provided to go to the original article. Kratomlords.com, it’s holding company, and it’s owners do not endorse any published content provided herein.

Kratomlords.com strongly recommends following FDA guidelines regarding Kratom. Please refer to the following link for further information. www.fda.gov/news-events/public-health-focus/fda-and-kratom

Leave a Comment

Comments

No comments yet. Why don’t you start the discussion?

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    WAAVE Compliance